Back to Woodline Partners LP

PTGX
Showing 8 of 9 quarters

Position history for Woodline Partners LP's holdings in PROTAGONIST THERAPEUTICS INC

Woodline Partners LP holds 1.4M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $149.1M as of 2026-Q1. The position was increased (+0.4% shares). PTGX represents 0.6% of Woodline Partners LP's portfolio.

Current Value

$149.1M

Current Shares

1.4M

Total Value Change

+$120.6M

Total Shares Change

+592,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.4M
+0.4%
$149.1M0.6%$91.30
43
2025-Q4
Decreased
1.4M
-2.0%
$123M0.5%$87.26
0
2025-Q3
Increased
1.4M
+51.9%
$95.5M0.4%$65.14
50
2025-Q2
Increased
946,884
+5.5%
$52.3M0.3%$55.69
37
2025-Q1
Increased
897,699
+54.2%
$43.4M0.3%$48.88
49
2024-Q4
Increased
582,327
+24.8%
$22.5M0.2%$38.51
42
2024-Q3
Decreased
466,518
-43.3%
$21M0.2%$44.56
0
2024-Q2
Increased
822,173
+29.1%
$28.5M0.3%$34.65
43

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used